COVID-19 – Does This Disease Kill Due to Imbalance of the Renin Angiotensin System (RAS) Caused by Genetic and Gender Differences in the Response to Viral ACE 2 Attack? - 06/08/20
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Debate continues in the medical literature on the role of the renin angiotensin system (RAS) in Coronavirus disease 2019 (COVID-19) pathophysiology and the implications for the use of cardiovascular drugs acting on the RAS. Could these drugs – which include angiotensin converting enzyme inhibitors (ACEIs) and angiotensin receptors blockers (ARBs) – be harmful or potential key therapeutic agents in COVID-19? And, could potentially helpful measures be available and in plain view on the pharmacy shelf?
Le texte complet de cet article est disponible en PDF.Keywords : COVID 19, Renin angiotensin system, Angiotensin converting enzyme inhibitors, Angiotensin receptor blockers, Neprilysin, Vitamin D
Plan
Vol 29 - N° 7
P. 964-972 - juillet 2020 Retour au numéro
Article précédent
- Mental Health and Psychosocial Challenges in the COVID-19 Pandemic: Food for Thought for Cardiovascular Health Care Professionals
- Adrienne O'Neil, Stephen J. Nicholls, Julie Redfern, Alex Brown, David L. Hare
- SARS-CoV-2 Infection and Cardiovascular Disease: COVID-19 Heart
- Bishnu P. Dhakal, Nancy K. Sweitzer, Julia H. Indik, Deepak Acharya, Preethi William
Bienvenue sur EM-consulte, la référence des professionnels de santé.